PHS
OMCL icon

PFM Health Sciences’s Omnicell OMCL Stock Holding History

PFM Health Sciences’s Portfolio OMCL Stock Details OMCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.04M Buy
+49,040
New +$1.98M 0.17% 91

Other funds holding OMCL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

PFM Health Sciences's OMCL Position: Q2 2026 in Review

PFM Health Sciences opened a new position in Omnicell (OMCL) in Q2 2026: 49,040 shares worth $2.04M. The stake represents 0.17% of the portfolio and ranks #91 among its holdings.

306 funds tracked by Wall St. Rank hold OMCL as of Q2 2026.

  • PFM Health Sciences held 49,040 shares of Omnicell worth $2.04M as of Q2 2026.
  • Omnicell was a new PFM Health Sciences position in Q2 2026.
  • Omnicell made up 0.17% of PFM Health Sciences's portfolio in Q2 2026, its #91 holding.
  • 306 funds tracked by Wall St. Rank held Omnicell as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.